Revolution Medicines priced a public offering of 10.56M shares at $142 each, raising about $1.5B, along with $500M of convertible senior notes due 2033. Both offerings were upsize ...

Telix Pharmaceuticals shares (ASX: TLX) pulled back 4.21% to A$14.80 as the radiopharmaceutical company upsized its convertible bond offering to US$600 million, raising fresh questions about potential ...

Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...

MELBOURNE, Australia and Indianapolis, April 15, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) ...

MELBOURNE, Australia and Indianapolis, April 14, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) ("Telix") is pleased to announce that it has successfully priced and ...

Gladstone Capital Corp (NASDAQ:GLAD) carries a yield near 10.4% and a monthly payment structure that appeals to ...

Borr Drilling Limited (NYSE and Euronext Growth Oslo: BORR) ("Borr Drilling" or the "Company") today announced that it intends to offer, subject to market and other conditions, $250 million aggregate ...

Borr Drilling Limited (NYSE:BORR) shares fell 6.5% in after-hours trading Tuesday following the company’s announcement of a proposed $250 million convertible senior notes offering. The offshore ...

ICICI Bank will discuss fundraising and buyback of debt securities at its board meeting on April 18, 2026. The bank will also ...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are in the spotlight on Wednesday. Here's why this radiopharmaceuticals stock is ...

Volato Group, Inc. (NYSE American: SOAR) ("Volato" or the "Company") today announced that it has suspended further borrowings/drawdowns under its convertible note facility (the "Facility"). The ...

Orthocell shares have surged on the back of the nerve repair house gaining access to US military and veterans' hospitals ...